Ventyx Biosciences's total assets for Q3 2023 were $321.70M, a decrease of -7.76% from the previous quarter. VTYX total liabilities were $38.06M for the fiscal quarter, a 81.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.